The Association Between Prepandemic ICU Performance and Mortality Variation in COVID-19 A Multicenter Cohort Study of 35,619 Critically Ill Patients

被引:2
|
作者
Bastos, Leonardo S. L. [1 ]
Hamacher, Silvio [1 ]
Kurtz, Pedro [2 ]
Ranzani, Otavio T. [4 ,5 ]
Zampieri, Fernando G. [2 ,6 ]
Soares, Marcio [2 ]
Bozza, Fernando A. [2 ,3 ]
Salluh, Jorge I. F. [2 ,3 ]
机构
[1] Pontif Catholic Univ Rio De Janeiro, Dept Ind Engn, Rio De Janeiro, RS, Brazil
[2] Hosp Copa Star, Dor Inst Res & Educ, Paulo Niemeyer State Brain Inst, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Oswaldo Cruz Fdn, Natl Inst Infect Dis Evandro Chagas, Postgrad Program Internal Med, Rio De Janeiro, Brazil
[4] Univ Sao Paulo, Hosp Clin HCFMUSP, Heart Inst, Fac Med,Pulm Div, Sao Paulo, Brazil
[5] Univ Pompeu Fabra, BarcelonaInstitute Global Hlth, ISGlobal, CIBER Epidemiol & Salud Publ, Barcelona, Spain
[6] Univ Alberta, Fac Med & Dent, Dept Crit Care Med, Edmonton, AB, Canada
基金
比尔及梅琳达.盖茨基金会;
关键词
COVID-19; ICU ef fi ciency; ICU organization; mortality; pandemic; INTENSIVE-CARE UNITS; RESOURCE USE; OUTCOMES; VOLUME;
D O I
10.1016/j.chest.2023.10.011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: During the COVID-19 pandemic, ICUs remained under stress and observed elevated mortality rates and high variations of outcomes. A knowledge gap exists regarding whether an ICU performing best during nonpandemic times would still perform better when under high pressure compared with the least performing ICUs. RESEARCH QUESTION: Does prepandemic ICU performance explain the risk-adjusted mortality variability for critically ill patients with COVID-19? STUDY DESIGN AND METHODS: This study examined a cohort of adults with real-time polymerase chain reaction-confirmed COVID-19 admitted to 156 ICUs in 35 hospitals from February 16, 2020, through December 31, 2021, in Brazil. We evaluated crude and adjusted in-hospital mortality variability of patients with COVID-19 in the ICU during the pandemic. Association of baseline (prepandemic) ICU performance and in-hospital mortality was examined using a variable life-adjusted display (VLAD) during the pandemic and a multivariable mixed regression model adjusted by clinical characteristics, interaction of performance with the year of admission, and mechanical ventilation at admission. RESULTS: Thirty-five thousand six hundred nineteen patients with confirmed COVID-19 were evaluated. The median age was 52 years, median Simplified Acute Physiology Score 3 was 42, and 18% underwent invasive mechanical ventilation. In-hospital mortality was 13% and 54% for those receiving invasive mechanical ventilation. Adjusted in-hospital mortality ranged from 3.6% to 63.2%. VLAD in the most efficient ICUs was higher than the overall median in 18% of weeks, whereas VLAD was 62% and 84% in the underachieving and least efficient groups, respectively. The least efficient baseline ICU performance group was associated independently with increased mortality (OR, 2.30; 95% CI, 1.45-3.62) after adjusting for patient characteristics, disease severity, and pandemic surge. INTERPRETATION: ICUs caring for patients with COVID-19 presented substantial variation in reduced mortality and less variability. Our findings suggest that achieving ICU efficiency by targeting improvement in organizational aspects of ICUs may impact outcomes, and therefore should be a part of the preparedness for future pandemics.
引用
收藏
页码:870 / 880
页数:11
相关论文
共 50 条
  • [21] Can statins reduce mortality in critically ill COVID-19 patients? A retrospective cohort study
    Labib, Heba A.
    Ali, Rania M.
    Tharwat, Ayman I.
    EGYPTIAN JOURNAL OF ANAESTHESIA, 2023, 39 (01): : 107 - 113
  • [22] The Impact of Age on In-Hospital Mortality in Critically Ill COVID-19 Patients: A Retrospective and Multicenter Study
    Le Borgne, Pierrick
    Dellenbach, Quentin
    Alame, Karine
    Noizet, Marc
    Gottwalles, Yannick
    Chouihed, Tahar
    Vuillaume, Laure Abensur
    Lavoignet, Charles-Eric
    Berard, Lise
    Molter, Lise
    Gennai, Stephane
    Kepka, Sabrina
    Lefebvre, Francois
    Bilbault, Pascal
    DIAGNOSTICS, 2022, 12 (03)
  • [23] The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study
    Al Sulaiman, Khalid
    Aljuhani, Ohoud
    Korayem, Ghazwa B.
    Altebainawi, Ali F.
    Vishwakarma, Ramesh
    Alfaifi, Mashael
    Alsohimi, Samiah
    Alrayes, Aljoharah
    Albishi, Sara
    Alqahtani, Reem
    Alalawi, Mai
    Al Sulaihim, Ibrahim
    Alanazi, Thamer A.
    Alqahtani, Rahaf A.
    Almagthali, Alaa
    Jomah, Shahamah
    Alshlowi, Areej
    Alshammari, Tahani R.
    Alzahrani, Shahad S.
    Abdulqader, Marwa I.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [24] The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study
    Al Sulaiman, Khalid
    Aljuhani, Ohoud
    Korayem, Ghazwa B.
    Altebainawi, Ali F.
    Vishwakarma, Ramesh
    AlFaifi, Mashael
    Alsohimi, Samiah
    Alrayes, Aljoharah
    Albishi, Sara
    Alqahtani, Reem
    Alalawi, Mai
    Al Sulaihim, Ibrahim
    Alanazi, Thamer A.
    Alqahtani, Rahaf A.
    Almagthali, Alaa
    Jomah, Shahamah
    Alshlowi, Areej
    Alshammari, Tahani R.
    Alzahrani, Shahad S.
    Abdulqader, Marwa I.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [25] Association between longitudinal changes in phase angle and mortality rate in adults critically ill with COVID-19: A retrospective cohort study
    Garcia-Grimaldo, Alan
    Trujillo-Mercado, Ander Samuel
    Rodriguez-Moguel, Nadia Carolina
    Rios-Ayala, Martin Armando
    Hernandez-Cardenas, Carmen Margarita
    Osuna-Padilla, Ivan Armando
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2024, 48 (08) : 974 - 981
  • [26] The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study
    Korayem, Ghazwa B.
    Aljuhani, Ohoud
    Altebainawi, Ali F.
    Al Shaya, Abdulrahman, I
    Alnajjar, Lina, I
    Alissa, Abdulrahman
    Aldhaeefi, Mohammed
    Kensara, Raed
    Al Muqati, Hessa
    Alhuwahmel, Abdulmohsen
    Alhuthaili, Omar
    Vishwakarma, Ramesh
    Aldardeer, Namareq
    Eljaaly, Khalid
    Alharbi, Aisha
    Al Harbi, Shmeylan
    Al Katheri, Abdulmalik
    Al Bekairy, Abdulkareem M.
    Aljedai, Ahmed
    Al Sulaiman, Khalid
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 252 - 259
  • [27] Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
    Ohoud Aljuhani
    Khalid Al Sulaiman
    Adel Alshabasy
    Khalid Eljaaly
    Abdulrahman I. Al Shaya
    Haytham Noureldeen
    Mohammed Aboudeif
    Bodoor Al Dosari
    Amina Alkhalaf
    Ghazwa B. Korayem
    Muneera M. Aleissa
    Hisham A. Badreldin
    Shmeylan Al Harbi
    Abdullah Alhammad
    Ramesh Vishwakarma
    BMC Infectious Diseases, 21
  • [28] Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
    Aljuhani, Ohoud
    Al Sulaiman, Khalid
    Alshabasy, Adel
    Eljaaly, Khalid
    Al Shaya, Abdulrahman I.
    Noureldeen, Haytham
    Aboudeif, Mohammed
    Al Dosari, Bodoor
    Alkhalaf, Amina
    Korayem, Ghazwa B.
    Aleissa, Muneera M.
    Badreldin, Hisham A.
    Al Harbi, Shmeylan
    Alhammad, Abdullah
    Vishwakarma, Ramesh
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [29] ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
    Vassiliou, Alice G.
    Keskinidou, Chrysi
    Jahaj, Edison
    Gallos, Parisis
    Dimopoulou, Ioanna
    Kotanidou, Anastasia
    Orfanos, Stylianos E.
    CELLS, 2021, 10 (01) : 1 - 13
  • [30] Protein and Energy Intake Assessment and Their Association With In-Hospital Mortality in Critically Ill COVID-19 Patients: A Prospective Cohort Study
    Hajimohammadebrahim-Ketabforoush, Melika
    Vahdat Shariatpanahi, Zahra
    Vahdat Shariatpanahi, Maryam
    Shahbazi, Erfan
    Shahbazi, Shaahin
    FRONTIERS IN NUTRITION, 2021, 8